Outlook Wealth Advisors’s Boston Scientific BSX Stock Holding History

Outlook Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,750	Closed	-$1.15M	–	294
2025 Q2	$1.15M	Sell	10,750 -26	-0.2%	-$2.63K	0.3%	62
2025 Q1	$1.09M	Buy	10,776 +168	+2%	+$16.9K	0.3%	63
2024 Q4	$948K	Buy	10,608 +15	+0.1%	+$1.32K	0.27%	70
2024 Q3	$888K	Sell	10,593 -217	-2%	-$17.1K	0.25%	78
2024 Q2	$832K	Sell	10,810 -209	-2%	-$15.3K	0.26%	77
2024 Q1	$755K	Sell	11,019 -893	-7%	-$57.4K	0.23%	89
2023 Q4	$689K	Sell	11,912 -3,031	-20%	-$162K	0.24%	88
2023 Q3	$789K	Buy	14,943 +751	+5%	+$39.4K	0.3%	78
2023 Q2	$768K	Sell	14,192 -81	-0.6%	-$4.23K	0.29%	83
2023 Q1	$714K	Buy	+14,273	New	+$673K	0.32%	78

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Outlook Wealth Advisors's BSX Position: Q3 2025 in Review

Outlook Wealth Advisors sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 10,750 shares — an estimated $1.15M sold.

Outlook Wealth Advisors first reported a position in BSX in Q1 2023 and held it in 10 quarters. The position peaked at $1.15M in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Outlook Wealth Advisors reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Outlook Wealth Advisors sold 10,750 Boston Scientific shares in Q3 2025, an estimated $1.15M.
Outlook Wealth Advisors first reported a position in Boston Scientific in Q1 2023 and held it in 10 quarters.
Outlook Wealth Advisors's Boston Scientific position peaked at $1.15M in Q2 2025.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Outlook Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.